Dolby Laboratories (DLB)
Cash ratio
| Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | ||
|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 701,893 | 482,047 | 745,364 | 620,127 | 1,225,380 |
| Short-term investments | US$ in thousands | 703 | 0 | 139,148 | 189,213 | 38,839 |
| Total current liabilities | US$ in thousands | 437,790 | 417,836 | 422,226 | 277,518 | 315,717 |
| Cash ratio | 1.60 | 1.15 | 2.09 | 2.92 | 4.00 |
September 30, 2025 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($701,893K
+ $703K)
÷ $437,790K
= 1.60
Peer comparison
Sep 30, 2025
Company name
Symbol
Cash ratio
Dolby Laboratories
DLB
1.60
Aramark Holdings
ARMK
0.18
Copart Inc
CPRT
7.01
Maximus Inc
MMS
0.29
Unifirst Corporation
UNF
0.72